Overview

Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and effectiveness of Thymosin Beta 4 administered topically in patients with Venous Stasis ulcers
Phase:
Phase 2
Details
Lead Sponsor:
RegeneRx Biopharmaceuticals, Inc.
Collaborator:
sigma-tau i.f.r. S.p.A.